Paul Hastings, Nkarta CEO and BIO chair

'Front and cen­ter': In­dus­try lead­ers call for re­sponse to Supreme Court abor­tion case draft

Biotech in­dus­try lead­ers want the drug de­vel­op­ment world to stand up and en­sure em­ploy­ees have ac­cess to abor­tions af­ter a draft rul­ing last week re­vealed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.